Research Article
Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics
Table 3
Cell viability of OCI-Ly3 and SU-DHL4 treated with WZ811.
| WZ811 concentration (μM) | Cell viability % |
| OCI-Ly3 | 0 (group 1) | 100 | 100 | 100 | 10 (group 2) | 79.99 | 86.18 | 83.95 | 20 (group 3) | 77.87 | 76.81 | 72.07 | 40 (group 4) | 68.54 | 68.69 | 70.56 | 80 (group 5) | 67.45 | 67.62 | 66.15 |
| SU-DHL4 | 0 (group 6) | 100 | 100 | 100 | 10 (group 7) | 98.75 | 91.94 | 98.8 | 20 (group 8) | 83.47 | 88.53 | 84.29 | 40 (group 9) | 73.31 | 78.82 | 75.12 | 80 (group 10) | 61.4 | 63.52 | 68.27 |
|
|